Literature DB >> 25850613

Mitochondria in autoinflammation: cause, mediator or bystander?

Robert van der Burgh1, Marianne Boes2.   

Abstract

People suffering from autoinflammatory disease (AID) have recurring sterile inflammation due to dysregulated inflammasome activation. Although certain genes have been associated with several AIDs, the molecular underpinnings of seemingly spontaneous inflammation are not well understood. Emerging data now suggest that mitochondrial reactive oxygen species (ROS), mitochondrial DNA (mtDNA), and autophagy might drive key signaling pathways towards activation of the inflammasome. In this review, we discuss recent findings and highlight common features between different AIDs and mitochondrial (dys)function. Although it is still early to identify clear therapeutic targets, the emerging paradigms in inflammation and mitochondrial biology show that mitochondria play an important role in AIDs, and understanding this interplay will be key in the development of new therapies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  autoinflammation; inflammasome; interleukin-1β; mitochondria

Mesh:

Substances:

Year:  2015        PMID: 25850613     DOI: 10.1016/j.tem.2015.03.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  10 in total

Review 1.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

Review 2.  The role of mitochondria in aging.

Authors:  Ji Yong Jang; Arnon Blum; Jie Liu; Toren Finkel
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

3.  The Mitochondria-Targeted Plastoquinone-Derivative SkQ1 Promotes Health and Increases Drosophila melanogaster Longevity in Various Environments.

Authors:  Eugenia Tsybul'ko; Anna Krementsova; Alexander Symonenko; Olga Rybina; Natalia Roshina; Elena Pasyukova
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-04-01       Impact factor: 6.053

Review 4.  Immunometabolism in early and late stages of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Rev Rheumatol       Date:  2017-03-31       Impact factor: 20.543

5.  PARP10 (ARTD10) modulates mitochondrial function.

Authors:  Judit Márton; Tamás Fodor; Lilla Nagy; András Vida; Gréta Kis; Attila Brunyánszki; Miklós Antal; Bernhard Lüscher; Péter Bai
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 6.  Operation of mitochondrial machinery in viral infection-induced immune responses.

Authors:  Jenn-Haung Lai; Shue-Fen Luo; Ling-Jun Ho
Journal:  Biochem Pharmacol       Date:  2018-08-31       Impact factor: 5.858

Review 7.  Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.

Authors:  Frouwkje A Politiek; Hans R Waterham
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

8.  Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.

Authors:  Jialin Xiao; Lauren Howard; Junxiang Wan; Emily Wiggins; Adriana Vidal; Pinchas Cohen; Stephen J Freedland
Journal:  Oncotarget       Date:  2017-08-10

9.  Mitochondrial CMPK2 mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathways.

Authors:  Jenn-Haung Lai; De-Wei Wu; Chien-Hsiang Wu; Li-Feng Hung; Chuan-Yueh Huang; Shuk-Man Ka; Ann Chen; Zee-Fen Chang; Ling-Jun Ho
Journal:  iScience       Date:  2021-05-03

Review 10.  The dual roles of autophagy and the GPCRs-mediating autophagy signaling pathway after cerebral ischemic stroke.

Authors:  Weichen Hou; Yulei Hao; Li Sun; Yang Zhao; Xiangyu Zheng; Lei Song
Journal:  Mol Brain       Date:  2022-02-02       Impact factor: 4.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.